The Supreme Court on Thursday unanimously rejected a challenge to the availability of mifepristone, a widely-used abortion pill. The ruling was based on procedural grounds and does not prevent future challenges to the drug’s access. Norah O’Donnell anchored CBS News’ special report on the decision.
FDA approves first self-administered flu vaccine spray
September 20, 2024
